Tehran Lipid and Glucose Study (TLGS)

Responding to a Growing Threat: Launched in 1999, the TLGS addressed the rising burden of non-communicable diseases (NCDs), particularly cardiovascular disease, in Iran. Longitudinal Design and Diverse Population: The study has followed over 15,000 individuals of all ages for over 20 years, providing valuable data on risk factor trends.
Community-Oriented Intervention: The TLGS goes beyond observation by implementing lifestyle interventions to reduce the risk of NCDs, such as type 2 diabetes. This sets it apart from many other cohort studies.
Focus on the Future: The study includes children and adolescents, allowing researchers to track risk factors from an early age and develop preventive strategies.
Embracing New Frontiers: The TLGS has recently incorporated genomics and metabolomics research, paving the way for personalized medicine approaches.